Back to Search Start Over

Criteria and regulatory considerations for the conditional approval of innovative antitumor drugs in China: from the perspective of clinical reviewers.

Authors :
Zou L
Qi Y
Jiang Y
Tang L
Du Y
Zhao B
Sun Y
Xiang M
Ma J
Yang Z
Source :
Cancer communications (London, England) [Cancer Commun (Lond)] 2023 Feb; Vol. 43 (2), pp. 171-176. Date of Electronic Publication: 2023 Jan 22.
Publication Year :
2023

Subjects

Subjects :
Humans
China
Antineoplastic Agents therapeutic use

Details

Language :
English
ISSN :
2523-3548
Volume :
43
Issue :
2
Database :
MEDLINE
Journal :
Cancer communications (London, England)
Publication Type :
Editorial & Opinion
Accession number :
36683350
Full Text :
https://doi.org/10.1002/cac2.12400
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details